March 30, 2022
Different toy same results
See if these statements seem at all familiar –
“Ypsomed (SWX:YPSN) announced today that it partnered with CamDiab to collaborate on managing automated insulin delivery with a mobile app.”
“Terumo (TSE:4543) and Glooko today announced a collaboration to integrate their technologies and create new diabetes data sharing solutions.”
Yes, it seems everyone has a shiny new toy that does way cool whiz bang things and will get absolutely crushed IF they ever really make it to market. The only surprising thing here is who will be doing the crushing. See way back in the day before the . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
